Clinical Trials Related to Bladder Cancer

Related studies linked through entity extraction aliases.

A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.

Status: NOT_YET_RECRUITING
Phase: PHASE3

The Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Patients With Variant Histologies Bladder Cancer Who Underwent Radical Cystectomy

Status: COMPLETED
Phase: N/A

The Man Van Project

Status: RECRUITING
Phase: NA

Pre-operative Immuno-Nutrition in Radical Cystectomy

Status: NOT_YET_RECRUITING
Phase: NA

Investigator Grant (IG) 2022 27746

Status: RECRUITING
Phase: NA

RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients

Status: RECRUITING
Phase: PHASE1/PHASE2

Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study

Status: RECRUITING
Phase: NA

Diagnostic Performance of the Vesical Imaging-Reporting and Data System (VI-RADS) in Detecting Muscle-invasive Bladder Tumour (MIBC) in Clinical Practice: Comparison With Transurethral Resection of Bladder Cancer (TURB) and Evaluation of Diagnostic Accuracy According to Tumour Location

Status: COMPLETED
Phase: N/A

Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer

Status: COMPLETED
Phase: N/A

Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

Status: RECRUITING
Phase: PHASE1

Antitumor T Cell Responses in Patients With Bladder Cancer

Status: NOT_YET_RECRUITING
Phase: N/A

A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC

Status: NOT_YET_RECRUITING
Phase: NA

Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer

Status: NOT_YET_RECRUITING
Phase: PHASE2

A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial

Status: WITHDRAWN
Phase: PHASE3

Bladder Cancer and Neoadjuvant Chemotherapy Efficiency Before Cystectomy

Status: ACTIVE_NOT_RECRUITING
Phase: N/A

First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours

Status: RECRUITING
Phase: NA

Stress-reducing Intervention in Urothelial Carcinoma

Status: RECRUITING
Phase: NA

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1